CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 160 filers reported holding CARDLYTICS INC in Q1 2022. The put-call ratio across all filers is 3.56 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,332,935 | +71.4% | 141,390 | -34.4% | 0.42% | +71.9% |
Q2 2023 | $1,361,145 | +29.1% | 215,371 | -30.7% | 0.24% | +18.0% |
Q1 2023 | $1,054,541 | -32.4% | 310,616 | +15.1% | 0.20% | -38.1% |
Q4 2022 | $1,559,536 | +173.1% | 269,816 | +344.3% | 0.33% | +143.4% |
Q3 2022 | $571,000 | -15.0% | 60,735 | +101.5% | 0.14% | -15.0% |
Q2 2022 | $672,000 | -57.3% | 30,142 | +5.3% | 0.16% | -49.4% |
Q1 2022 | $1,575,000 | -15.5% | 28,638 | +1.5% | 0.32% | -15.3% |
Q4 2021 | $1,865,000 | +11.5% | 28,222 | +41.7% | 0.37% | -27.9% |
Q3 2021 | $1,672,000 | -11.9% | 19,922 | +33.3% | 0.52% | -7.5% |
Q2 2021 | $1,897,000 | +24.8% | 14,949 | +7.9% | 0.56% | +0.7% |
Q1 2021 | $1,520,000 | -24.7% | 13,852 | -2.1% | 0.56% | -29.9% |
Q4 2020 | $2,019,000 | +62.8% | 14,144 | -19.5% | 0.79% | +21.8% |
Q3 2020 | $1,240,000 | +4.2% | 17,577 | +3.3% | 0.65% | -21.6% |
Q2 2020 | $1,190,000 | +100.0% | 17,011 | -0.1% | 0.83% | +40.7% |
Q1 2020 | $595,000 | – | 17,026 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
Cannell Capital | 626,975 | $16,289,000 | 4.62% |
Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |